Description
GSK-2830371isaninhibitorofwild-typep53-inducedphosphatase1(Wip1)thatexhibitsanticancerchemotherapeuticactivity.Inanimalmodelsoflymphoma,GSK-2830371inhibitscellgrowthandtumorgrowth.Inneuroblastomacells,thiscompoundinducescelldeath.
GSK-2830371isaninhibitorofwild-typep53-inducedphosphatase1(Wip1)thatexhibitsanticancerchemotherapeuticactivity.Inanimalmodelsoflymphoma,GSK-2830371inhibitscellgrowthandtumorgrowth.Inneuroblastomacells,thiscompoundinducescelldeath.
| CasNo. | 1404456-53-6 |
|---|---|
| Purity | ≥98% |
| Formula | C23H29ClN4O2S |
| FormulaWt. | 461.02 |
| IUPACName | 5-{[(5-Chloro-2-methyl-3-pyridinyl)amino]methyl}-N-[(2S)-3-cyclopentyl-1-(cyclopropylamino)-1-oxo-2-propanyl]-2-thiophenecarboxamide |
| Appearance | Yellowtooffwhitepowder |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | G7240InfoSheetPDF |
|---|
RichterM,DayaramT,GilmartinAG,etal.WIP1PhosphataseasaPotentialTherapeuticTargetinNeuroblastoma.PLoSOne.2015Feb6;10(2):e0115635.PMID:25658463.
GilmartinAG,FaitgTH,RichterM,etal.AllostericWip1phosphataseinhibitionthroughflap-suBDomaininteraction.NatChemBiol.2014Mar;10(3):181-7.PMID:24390428.